Response to "Suspected differential interactions of digoxin with imidafenacin and propantheline; some thoughts for introspection".
Nakade
Susumu
S
Ohno
Tomoya
T
Ogawa
Mikio
M
D001682:Biological Availability; D018680:Cholinergic Antagonists / Q000494:pharmacology*; D004077:Digoxin / Q000494:pharmacology*; D004347:Drug Interactions / Q000502:physiology*; D006801:Humans; D007093:Imidazoles / Q000494:pharmacology*; D011413:Propantheline / Q000494:pharmacology*; D011812:Quinuclidines / Q000494:pharmacology; D011976:Receptors, Muscarinic / Q000187:drug effects; D000069464:Solifenacin Succinate; D044005:Tetrahydroisoquinolines / Q000494:pharmacology
D018680:Cholinergic Antagonists; D007093:Imidazoles; D011812:Quinuclidines; D011976:Receptors, Muscarinic; D044005:Tetrahydroisoquinolines; D011413:Propantheline; D004077:Digoxin; D000069464:Solifenacin Succinate; C120953:imidafenacin